Understanding physician and consumer attitudes concerning cholesterol management: Results from the National Lipid Association Surveys

被引:6
作者
Pasternak, RC
McKenney, JM
Brown, WV
Cahill, E
Cohen, JD
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Natl Clin Res Inc, Richmond, VA USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
[4] Appl Res & Consulting LLC, New York, NY USA
[5] St Louis Univ, Sch Med, St Louis, MO USA
关键词
D O I
10.1016/j.amjcard.2004.07.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two online surveys commissioned by the National Lipid Association (NLA) were conducted to determine the current attitudes of physicians and consumers regarding cholesterol and heart disease. Physicians and consumers from preexisting independent panels were randomly invited to participate in the online surveys that were open from January 26 to 30, 2004. Both physicians (n = 200) and consumers (n = 600) agreed that high cholesterol and coronary artery disease (CAD) are significant health risks. Physicians reported the primary barriers for patients being prescribed cholesterol-lowering medication as patient fear of side effects (61%) and reluctance to take prescription medications (52%). While most physicians were aware of and felt they adhered to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines, considerably fewer thought the same of other physicians. The con-sumer survey focused on untreated moderate-risk patients (an approximate 10% to 20% 10-year risk of myocardial infarction and cardiac death) because this group is often undertreated. Untreated moderate-risk patients reported that their physicians did not advise them to take prescription cholesterol-lowering drugs (51%) and that they were trying to control their cholesterol with diet and exercise (58%). Consumers believe they are taking an increased role in their own health management and decision making. Current attitudes of physicians and consumers are similar with regard to their recognition of the significance of cholesterol and CAD. for health, but differ with regard to why patients do not take prescription medications. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:9F / 15F
页数:7
相关论文
共 14 条
[1]  
*AM HEART ASS AM S, 2004, HEART DIS STROK STAT
[2]  
[Anonymous], 2002, NIH PUBL
[3]   Reductase inhibitor monotherapy and stroke prevention [J].
Crouse, JR ;
Byington, RP ;
Hoen, HM ;
Furberg, CD .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (12) :1305-1310
[4]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[5]  
Dubois RW, 2002, AM J MANAG CARE, V8, P862
[6]   Communicating evidence for participatory decision making [J].
Epstein, RM ;
Alper, BS ;
Quill, TE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (19) :2359-2366
[7]  
*GREENF ONL INC, 2003, ONL RES SURV NEW HIG
[8]   Effect of statins on risk of coronary disease - A meta-analysis of randomized controlled trials [J].
LaRosa, JC ;
He, J ;
Vupputuri, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24) :2340-2346
[9]   Contemporary awareness and understanding of cholesterol as a risk factor - Results of an American heart association national survey [J].
Nash, IS ;
Mosca, L ;
Blumenthal, RS ;
Davidson, MH ;
Smith, SC ;
Pasternak, RC .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1597-1600
[10]  
*NAT CONS LEAG, SURV CONS ATT CHOL L